SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Generic: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE
Advagen Pharma Ltd.Manufacturer
ORALRoute
SPIRONOLACTONEActive Substance
2026-09-10Original Approval
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE is FDA application ANDA220884, sponsored by RUBICON RESEARCH. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DYSPNOEA
9,140 reports
2
FATIGUE
7,454 reports
3
NAUSEA
6,967 reports
4
DIARRHOEA
6,594 reports
5
ACUTE KIDNEY INJURY
5,710 reports
6
DIZZINESS
5,694 reports
7
HEADACHE
5,599 reports
8
OFF LABEL USE
5,203 reports
9
DRUG INEFFECTIVE
4,937 reports
10
HYPOTENSION
4,914 reports